Page 13 - 69404d10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) – Investment analysts at Zacks Research lowered their Q3 2023 earnings estimates for shares of Pacific Biosciences of California in a note issued to investors on Monday, April 3rd. Zacks Research analyst I. Bandyopadhyay now forecasts that the biotechnology company will post earnings per share of […]

TD Cowen upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Get Rating) from a market perform rating to an outperform rating in a research report report published on Friday, Marketbeat.com reports. TD Cowen currently has $15.00 price objective on the biotechnology company’s stock, up from their previous price objective of $13.00. PACB has been […]

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) have been assigned an average rating of “Hold” from the seven research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and one has given a buy […]

Vontobel Holding Ltd. decreased its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) by 91.0% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 10,362 shares of the biotechnology company’s stock after selling 105,283 shares during the period. Vontobel Holding Ltd.’s holdings in Pacific Biosciences of California were worth $47,000 […]

Versor Investments LP purchased a new stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,000 shares of the biotechnology company’s stock, valued at approximately $44,000. A […]